US NGO in eye of Indian storm after panel reports HPV vaccine trial irregularities

Another damning report by an Indian parliamentary panel on clinical trials, this time with scathing comments against the US-based non-profit organization PATH over the conduct of studies concerning human papillomavirus (HPV) vaccines, could potentially have serious implications for Merck & Co's Gardasil and GlaxoSmithKline's Cervarix vaccines in the country1.